←
UCI MIND2,316 posts
UCI MIND avatar

UCI MIND

@ucimind

Home to one of 35 #Alzheimer’s Disease #Research Centers funded by the @NIH National Institute on Aging and one of 10 California Alzheimer’s Disease Centers

◷ Joined July 2009▧ 751 Photos and videos
Alzheimer's Association Orange County avatar
⟳ UCI MIND retweeted
Alzheimer's Association Orange County@endalzoc·Aug 18

💙 The fight against Alzheimer’s starts with YOU! Join leading researchers, clinicians, caregivers & advocates at the 37th Annual Southern California Alzheimer’s Disease Research Conference on Sept. 25 in Irvine. 🧠 Early Bird: $100 through Aug. 24! 🎟️conference.mind.uci.edu

Post attachment
UCI Social Ecology avatar
⟳ UCI MIND retweeted
UCI Social Ecology@Social_Ecology·Apr 28

Congratulations to @UCIrvine alumna Ivanna Zuniga ('23, BA psychological science) for returning to campus as a Staff Research Associate 1, working with Associate Professor of neurology Crystal Glover at @ucimind. Ivanna was a peer tutor for psychology Professor Joanne Zinger.

Post attachment
UC Irvine avatar
⟳ UCI MIND retweeted
UC Irvine@UCIrvine·Mar 18

Women are driving discovery at UC Irvine. From cancer care to cosmic breakthroughs, UC Irvine’s female researchers are expanding the frontiers of science. uci.edu/ #WomensHistoryMonth

Post attachment
Suzanne E Schindler avatar
⟳ UCI MIND retweeted
Suzanne E Schindler@SuzanneESchind1·Feb 19

🩸 🧠 ⏱️ What if a blood test could predict WHEN an individual would develop symptoms of Alzheimer’s disease? High plasma p-tau217 predicts greater risk for Alzheimer’s symptoms—do the plasma p-tau217 levels provide insights into WHEN symptoms might begin? We found that after a certain level, plasma p-tau217 increased consistently across individuals and allowed creation of “clock” models that could be used to estimate age at p-tau217 abnormality (nature.com/articles/s41591-0…). The age at p-tau217 abnormality was strongly associated with the age that Alzheimer’s symptoms began. Interestingly, older individuals developed symptoms more quickly after p-tau217 abnormality. These models are not yet accurate enough to be useful to individuals, but we expect they can be improved by adding additional blood biomarkers and clinical features. We have created an application to view the results (amyloid.shinyapps.io/plasma_…) and shared all our code to accelerate progress. The eventual goal is to help individuals to understand their likelihood of developing Alzheimer’s symptoms. @KellenPetersen @FNIH_Org @WashUNeurology @alzassociation #ENDALZ

BrightFocus Foundation avatar
⟳ UCI MIND retweeted
BrightFocus Foundation@_BrightFocus·Feb 18

Could we prevent Alzheimer's before memory loss begins? Dr. Joshua Grill explains how researchers are exploring early treatment to slow or stop brain changes associated with Alzheimer’s disease in people at higher risk. Learn more about this promising area of research ➡️ bit.ly/4k3QPMP.

0:54
BrightFocus Foundation avatar
⟳ UCI MIND retweeted
BrightFocus Foundation@_BrightFocus·Jan 26

A clinical trial is testing whether early treatment with the drug lecanemab, already FDA-approved for individuals with Alzheimer's, could prevent memory loss before it starts. Dr. Joshua D. Grill of @ucimind discusses the AHEAD study, which is enrolling people with normal memory but who show early brain changes linked to Alzheimer's. Results could reshape how we approach dementia prevention. Watch the full episode: bit.ly/4k3QPMP

1:15
UC Irvine avatar
⟳ UCI MIND retweeted
UC Irvine@UCIrvine·8 Dec 2025

A $50 million gift from the Quilter family & $30 million in new commitments propel @ucimind to build state-of-the-art research & care facility for Alzheimer’s & dementia. @UCIAA Charles and Ann Quilter & family made the generous contribution. 🔗 bit.ly/4rKvFXa

Post attachment